603259 Wuxi Apptec Co.,Ltd.
Closed 01-10 15:00:00
53.36
+0.75
+1.43%
High
54.30
Low
52.94
Vol
33.45M
Open
53.47
D1 Closing
52.61
Amplitude
2.59%
Mkt Cap
154.10B
Tradable Cap
133.45B
Total Shares
2.89B
T/O
1.80B
T/O Rate
1.34%
Tradable Shares
2.50B
P/B
2.79
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
Dow Jones · 01-07
China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million
Reuters · 01-06
China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million
BlackRock Inc's Long Position in H-Shares of WuXi AppTec Increases to 6.01% on Dec 23 From 4.72% - HKEX
THOMSON REUTERS · 2024-12-27
BlackRock Inc's Long Position in H-Shares of WuXi AppTec Increases to 6.01% on Dec 23 From 4.72% - HKEX
WuXi AppTec's Sale of Advanced Therapies Unit Likely to Alleviate U.S. Concerns -- Market Talk
Dow Jones · 2024-12-27
WuXi AppTec's Sale of Advanced Therapies Unit Likely to Alleviate U.S. Concerns -- Market Talk
WuXi AppTec Sells Cell, Gene Therapy Unit
MT Newswires Live · 2024-12-26
WuXi AppTec Sells Cell, Gene Therapy Unit
China's WuXi to sell Advanced Therapies unit amid US restrictions
Reuters · 2024-12-24
China's WuXi to sell Advanced Therapies unit amid US restrictions
BRIEF-Wuxi Apptec Says Units To Sell All Shares in Wuxi Advanced Therapies to Altaris LLC
Reuters · 2024-12-24
BRIEF-Wuxi Apptec Says Units To Sell All Shares in Wuxi Advanced Therapies to Altaris LLC
WuXi AppTec - Business Update in Connection With Wuxi Atu Business
THOMSON REUTERS · 2024-12-24
WuXi AppTec - Business Update in Connection With Wuxi Atu Business
WuXi AppTec - Units to Sell All of Shares in Wuxi Advanced Therapies Inc. to Altaris Llc
THOMSON REUTERS · 2024-12-24
WuXi AppTec - Units to Sell All of Shares in Wuxi Advanced Therapies Inc. to Altaris Llc
WuXi AppTec's WuXi Fund I to Subscribe to Sofinnova Biovelocita II, Sofinnova Crossover II
MT Newswires Live · 2024-12-20
WuXi AppTec's WuXi Fund I to Subscribe to Sofinnova Biovelocita II, Sofinnova Crossover II
WuXi AppTec Says Unit Plans to Subscribe for Shares in Two Private Investment Funds With a Total of 20 Mln Euros
THOMSON REUTERS · 2024-12-19
WuXi AppTec Says Unit Plans to Subscribe for Shares in Two Private Investment Funds With a Total of 20 Mln Euros
BRIEF-JPMorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Decreases To 9.93% On Dec 12 - HKEX
Reuters · 2024-12-18
BRIEF-JPMorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Decreases To 9.93% On Dec 12 - HKEX
JPMorgan Chase & Co's Long Position in H-Shares of WuXi AppTec Decreases to 9.93% on Dec 12 From 10.52% - HKEX
THOMSON REUTERS · 2024-12-18
JPMorgan Chase & Co's Long Position in H-Shares of WuXi AppTec Decreases to 9.93% on Dec 12 From 10.52% - HKEX
BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Increases To 10.83% On Dec 9 From 9.55% - HKEX Filing
Reuters · 2024-12-13
BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Increases To 10.83% On Dec 9 From 9.55% - HKEX Filing
BRIEF-UBS Group AG's Long Position In H-Shares Of Wuxi Apptec Increases To 5.63% On Dec 9 From 4.99% - HKEX
Reuters · 2024-12-13
BRIEF-UBS Group AG's Long Position In H-Shares Of Wuxi Apptec Increases To 5.63% On Dec 9 From 4.99% - HKEX
JPMorgan Chase & Co's Short Position in H-Shares of WuXi AppTec Increases to 3.23% on Dec 9 From 2.07% - HKEX
THOMSON REUTERS · 2024-12-13
JPMorgan Chase & Co's Short Position in H-Shares of WuXi AppTec Increases to 3.23% on Dec 9 From 2.07% - HKEX
UBS Group Ag's Long Position in H-Shares of WuXi AppTec Increases to 5.63% on Dec 9 From 4.99% - HKEX
THOMSON REUTERS · 2024-12-13
UBS Group Ag's Long Position in H-Shares of WuXi AppTec Increases to 5.63% on Dec 9 From 4.99% - HKEX
BRIEF-Jpmorgan Chase & Co's Long Position In H Shares Of Wuxi Apptec Increases To 9.55% - HKEX
Reuters · 2024-12-11
BRIEF-Jpmorgan Chase & Co's Long Position In H Shares Of Wuxi Apptec Increases To 9.55% - HKEX
JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Increases to 9.55% on Dec 6 From 8.98% - HKEX
THOMSON REUTERS · 2024-12-11
JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Increases to 9.55% on Dec 6 From 8.98% - HKEX
Hong Kong Stocks Begin Week in Green; WuXi AppTec, WuXi Biologics Jump 9%
MT Newswires Live · 2024-12-09
Hong Kong Stocks Begin Week in Green; WuXi AppTec, WuXi Biologics Jump 9%
Load more
Introduction
Company Name.
无锡药明康德新药开发股份有限公司
Industry:
研究和试验发展
Listing Date:
2018-05-08
Main Business:
无锡药明康德新药开发股份有限公司的主营业务是为全球生物医药行业提供一体化、端到端的新药研发和生产服务。公司主营业务可以分为化学业务、测试业务、生物学业务、细胞及基因疗法CTDMO业务、国内新药研发服务业务五大板块，服务范围覆盖从概念产生到商业化生产的整个流程，服务区域包括中国、美国、欧洲及其他区域。
Issue price:
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"Wuxi Apptec Co.,Ltd.","latestPrice":53.36,"timestamp":1736492400000,"preClose":52.61,"halted":0,"volume":33453661,"delay":0,"changeRate":0.0143,"floatShares":2501000000,"shares":2888000000,"eps":2.7921,"marketStatus":"Closed","change":0.75,"latestTime":"01-10 15:00:00","open":53.47,"high":54.3,"low":52.94,"amount":1798000000,"amplitude":0.0259,"askPrice":53.38,"askSize":14,"bidPrice":53.36,"bidSize":1,"shortable":0,"etf":0,"ttmEps":2.7921,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1736731800000},"marketStatusCode":5,"adr":0,"adjPreClose":52.61,"symbolType":"stock","openAndCloseTimeList":[[1736472600000,1736479800000],[1736485200000,1736492400000]],"highLimit":57.87,"lowLimit":47.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2887992582,"isCdr":false,"pbRate":2.79,"roa":"--","peRate":19.111063,"roe":"11.73%","epsLYR":3.27,"committee":-0.694656,"marketValue":154103000000,"turnoverRate":0.0134,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"WUXI APPTEC","latestPrice":53.45,"timestamp":1736496483015,"preClose":52.75,"halted":0,"volume":2977967,"delay":0,"premium":"-5.36"},"floatMarketCap":133449000000},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2501292221","title":"China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2501292221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501292221?lang=en_us&edition=fundamental","pubTime":"2025-01-07 16:23","pubTimestamp":1736238180,"startTime":"0","endTime":"0","summary":"0822 GMT - China's healthcare sector will likely get a significant boost from national policies in 1Q, Citi analysts write in a note. This year marks the start of the most positive structural change in the industry, as it will be the first time that China's public healthcare system is able to include commercial insurance providers as significant payers, they say. The brokerage recommends buying shares in companies that will be direct beneficiaries of the reform. These include pharmaceutical and biopharmaceutical firms, pharmaceutical distributors and medical device companies. Citi's top picks include Jiangsu Hengrui Medicine, Hansoh Pharmaceutical, SSY Group, Akeso, Sichuan Kelun-Biotech Biopharmaceutical, Mindray Medical, Sinopharm Group, WuXi AppTec, Wuxi Biologics and Gushengtang. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU1242518857.USD","LU0359202008.SGD","600276","LU0640798160.USD","LU1064131003.USD","02005","LU0140636845.USD","HCSG","LU0819121731.USD","03692","BK0188","01099","LU0348735423.USD","LU1880383366.USD","02273","LU0979878070.USD","BK1589","LU0516422366.SGD","06990","BK1610","LU2460026573.USD","LU1328615791.USD","SHTDY","BK0196","LU0326950275.SGD","LU1997245094.SGD","LU0359201612.USD","LU0456846285.SGD","02269","603259","BK1576","LU0052750758.USD","LU0516423174.USD","IE00B543WZ88.USD","LU0405327148.USD","BK1583","LU0588546209.SGD","09926","LU0039217434.USD","LU0196878994.USD","LU0348784397.USD","BK1574","LU0856984785.SGD","BK1219","LU0516422440.USD","BK0012","BK1191","LU0516422952.EUR","BK4137"],"gpt_icon":0},{"id":"2501253933","title":"China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2501253933","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501253933?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:59","pubTimestamp":1736175550,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 millionAdds details on bill in paragraph 3-4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nL4N3O20YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","02269","SG9999002562.SGD","LU0456827905.SGD","LU0588546209.SGD","LU1585245621.USD","LU0348735423.USD","IE00BSNM7G36.USD","LU1941712264.USD","LU1941712348.USD","LU2324357040.USD","LU0058720904.USD","LU0985320562.USD","SG9999001440.SGD","LU1794554557.SGD","BK1576","LU0320764599.SGD","LU0181495838.USD","MRK","LU1989772923.USD","LU0006306889.USD","LU2361045086.USD","LU0861579265.USD","LU2023250843.SGD","LU1974910355.USD","LU2361044949.HKD","BK4533","SG9999002224.SGD","LU0238689110.USD","LU0819121731.USD","SG9999014575.USD","LU0203345920.USD","IE00B0JY6N72.USD","LU0823426480.USD","LU0856984785.SGD","BK1589","BK4550","BK0216","SG9999001176.USD","LU0106261372.USD","LU2361044865.SGD","603259","LU0140636845.USD","IE00B2B36J28.USD","LU1983299246.USD","LU1688375341.USD","LU1066051811.HKD","LU1291159041.SGD","LU0348825331.USD","LU0965508806.USD"],"gpt_icon":0},{"id":"2494717458","title":"BlackRock Inc's Long Position in H-Shares of WuXi AppTec Increases to 6.01% on Dec 23 From 4.72% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2494717458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494717458?lang=en_us&edition=fundamental","pubTime":"2024-12-27 17:16","pubTimestamp":1735290981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nFWN3NR09T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02359","LU2488822045.USD","LU0456842615.SGD","BK1141","BK1576","LU2045819591.USD","LU1997245094.SGD","BK0216","LU1046422090.SGD","603259","LU0320764599.SGD","LU2242644610.SGD","LU2125910500.SGD","LU0052750758.USD","LU0708995583.HKD","BK1583","LU1997245177.USD"],"gpt_icon":0},{"id":"2494844859","title":"WuXi AppTec's Sale of Advanced Therapies Unit Likely to Alleviate U.S. Concerns -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2494844859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494844859?lang=en_us&edition=fundamental","pubTime":"2024-12-27 10:52","pubTimestamp":1735267920,"startTime":"0","endTime":"0","summary":"0252 GMT - WuXi AppTec's sale of its Advanced Therapies unit is likely to alleviate U.S. security concerns, Citi Research analysts write in a note. The cell and gene therapy manufacturing unit is the business segment that the U.S. is worried about and affected by the Biosecure Act, which could restrict WuXi's operations in the U.S., Citi says. The sale will allow transactions to continue without interrupting patient treatments, Citi adds. Given the limited time left for the Senate to vote on the Biosecure Act under the Biden Administration, it lowers the geopolitical risks for WuXi going into 2025, Citi says. Citi retains a buy rating with a target price of HK$74.00. Shares are 3.2% lower at HK$53.85. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEIS","BK4157","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK6522","BLZ.SI","IE0031619046.USD","603259","BK0216","LU2488822045.USD","LU1997245177.USD","IE00B66KJ199.SGD","BK6088","LU0456842615.SGD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2494882269","title":"WuXi AppTec Sells Cell, Gene Therapy Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2494882269","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494882269?lang=en_us&edition=fundamental","pubTime":"2024-12-26 13:53","pubTimestamp":1735192435,"startTime":"0","endTime":"0","summary":"WuXi AppTec agreed to sell the US and UK-based operations of its cell and gene therapy unit, WuXi Advanced Therapies, to healthcare investment firm Altaris.The transaction is expected to close in the first half of 2025, according to a Dec. 24 filing.The price of the transaction was not disclosed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["603259","LU0456842615.SGD","LU1997245094.SGD","LU1997245177.USD","LU2488822045.USD","BK0216"],"gpt_icon":0},{"id":"2493082813","title":"China's WuXi to sell Advanced Therapies unit amid US restrictions","url":"https://stock-news.laohu8.com/highlight/detail?id=2493082813","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493082813?lang=en_us&edition=fundamental","pubTime":"2024-12-24 22:24","pubTimestamp":1735050276,"startTime":"0","endTime":"0","summary":"UPDATE 1-China's WuXi to sell Advanced Therapies unit amid US restrictionsAdds background and details in paragraphs 2-6. Dec 24 - China's WuXi AppTec 603259.SS said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed sum.The company, along with other Chinese firms, have been at the center of new U.S. laws aimed at restricting their businesses in the United States due to national security concerns.The U.S. House of Representatives had passed a bill in September which would prohibit federal contracts with targeted firms and those that do business with them.The bills are designed to keep Americans' personal health and genetic information from foreign adversaries and aim to push U.S. pharmaceutical and biotech companies to lessen their reliance on China for everything from drug ingredient manufacturing to early research.WuXi said it would als","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nL4N3NP0OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","LU2488822045.USD","LU1997245177.USD","LU1997245094.SGD","LU0456842615.SGD","BK0216"],"gpt_icon":0},{"id":"2493703089","title":"BRIEF-Wuxi Apptec Says Units To Sell All Shares in Wuxi Advanced Therapies to Altaris LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2493703089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493703089?lang=en_us&edition=fundamental","pubTime":"2024-12-24 21:40","pubTimestamp":1735047627,"startTime":"0","endTime":"0","summary":"BRIEF-Wuxi Apptec Says Units To Sell All Shares in Wuxi Advanced Therapies to Altaris LLCDec 24 - WuXi AppTec Co Ltd 603259.SS:BUSINESS UPDATE IN CONNECTION WITH WUXI ATU BUSINESSUNITS TO SELL ALL OF SHARES IN WUXI ADVANCED THERAPIES INC. TO ALTARIS LLCFurther company coverage: 603259.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nFWN3NP0HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","BK1141","02359","LU0320764599.SGD","LU2125910500.SGD","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD","LU2488822045.USD","LU1046422090.SGD","LU0052750758.USD","LU1997245177.USD","BK1576","BK1583","LU1997245094.SGD","BK0216","LU0456842615.SGD"],"gpt_icon":0},{"id":"2493908940","title":"WuXi AppTec - Business Update in Connection With Wuxi Atu Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2493908940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493908940?lang=en_us&edition=fundamental","pubTime":"2024-12-24 21:37","pubTimestamp":1735047442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nFWN3NP0HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1997245177.USD","BK0216","BK1576","LU2125910500.SGD","LU0456842615.SGD","LU0708995583.HKD","LU2488822045.USD","BK1583","LU2045819591.USD","LU1046422090.SGD","LU0052750758.USD","LU0320764599.SGD","BK1141","LU1997245094.SGD","603259","LU2242644610.SGD","02359"],"gpt_icon":0},{"id":"2493089404","title":"WuXi AppTec - Units to Sell All of Shares in Wuxi Advanced Therapies Inc. to Altaris Llc","url":"https://stock-news.laohu8.com/highlight/detail?id=2493089404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493089404?lang=en_us&edition=fundamental","pubTime":"2024-12-24 21:37","pubTimestamp":1735047442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nFWN3NP0HG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","LU0052750758.USD","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","LU2488822045.USD","LU1997245094.SGD","603259","LU0320764599.SGD","LU1046422090.SGD","LU1997245177.USD","BK1576","LU2125910500.SGD","02359","BK1583","BK1141","LU0456842615.SGD"],"gpt_icon":0},{"id":"2492492133","title":"WuXi AppTec's WuXi Fund I to Subscribe to Sofinnova Biovelocita II, Sofinnova Crossover II","url":"https://stock-news.laohu8.com/highlight/detail?id=2492492133","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492492133?lang=en_us&edition=fundamental","pubTime":"2024-12-20 17:45","pubTimestamp":1734687945,"startTime":"0","endTime":"0","summary":"Biotechnology company WuXi AppTec said subsidiary WuXi Fund I intends to subscribe for about 75 million yuan each in the shares of Sofinnova Biovelocita II and Sofinnova Crossover II as a limited partner.The investments comprise 6.89% of Sofinnova Biovelocita II's raised shares and 1.61% of Sofinnova Crossover II's raised shares, according to a Friday filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1997245177.USD","LU0456842615.SGD","BK0216","LU2488822045.USD","LU1997245094.SGD","603259"],"gpt_icon":0},{"id":"2492761120","title":"WuXi AppTec Says Unit Plans to Subscribe for Shares in Two Private Investment Funds With a Total of 20 Mln Euros","url":"https://stock-news.laohu8.com/highlight/detail?id=2492761120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492761120?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:27","pubTimestamp":1734614868,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4N3NK168:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","LU2488822045.USD","LU1997245094.SGD","603259","LU1997245177.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2492903187","title":"BRIEF-JPMorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Decreases To 9.93% On Dec 12 - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2492903187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492903187?lang=en_us&edition=fundamental","pubTime":"2024-12-18 18:13","pubTimestamp":1734516784,"startTime":"0","endTime":"0","summary":"BRIEF-JPMorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Decreases To 9.93% On Dec 12 - HKEXDec 18 - JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF WUXI APPTEC 2359.HK DECREASES TO 9.93% ON DEC 12 FROM 10.52% - HKEXFurther company coverage: 2359.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","LU1997245094.SGD","LU2488822045.USD","LU2125910500.SGD","603259","LU2242644610.SGD","BK1141","BK1583","02359","LU0708995583.HKD","LU0456842615.SGD","LU1997245177.USD","BK1576","LU2045819591.USD"],"gpt_icon":0},{"id":"2492972504","title":"JPMorgan Chase & Co's Long Position in H-Shares of WuXi AppTec Decreases to 9.93% on Dec 12 From 10.52% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2492972504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492972504?lang=en_us&edition=fundamental","pubTime":"2024-12-18 17:08","pubTimestamp":1734512892,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910500.SGD","LU0708995583.HKD","LU0052750758.USD","BK1576","BK1583","LU1046422090.SGD","LU2242644610.SGD","BK1141","LU0456842615.SGD","LU1997245177.USD","LU2045819591.USD","LU1997245094.SGD","BK0216","02359","603259","LU2488822045.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2491340674","title":"BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Increases To 10.83% On Dec 9 From 9.55% - HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2491340674","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491340674?lang=en_us&edition=fundamental","pubTime":"2024-12-13 18:32","pubTimestamp":1734085962,"startTime":"0","endTime":"0","summary":"BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Increases To 10.83% On Dec 9 From 9.55% - HKEX FilingDec 13 - HKEX:JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF WUXI APPTEC 2359.HK INCREASES TO 10.83% ON DEC 9 FROM 9.55% - HKEX FILINGJPMORGAN CHASE & CO'S SHORT POSITION IN H-SHARES OF WUXI APPTEC 2359.HK INCREASES TO 3.23% ON DEC 9 FROM 2.07% - HKEXFurther company coverage: 2359.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","BK1141","02359","LU0320764599.SGD","LU2125910500.SGD","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD","LU2488822045.USD","LU1046422090.SGD","LU0052750758.USD","LU1997245177.USD","BK1576","BK1583","LU1997245094.SGD","BK0216","LU0456842615.SGD"],"gpt_icon":0},{"id":"2491340691","title":"BRIEF-UBS Group AG's Long Position In H-Shares Of Wuxi Apptec Increases To 5.63% On Dec 9 From 4.99% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2491340691","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491340691?lang=en_us&edition=fundamental","pubTime":"2024-12-13 18:30","pubTimestamp":1734085855,"startTime":"0","endTime":"0","summary":"BRIEF-UBS Group AG's Long Position In H-Shares Of Wuxi Apptec Increases To 5.63% On Dec 9 From 4.99% - HKEXDec 13 - HKEX:UBS GROUP AG'S LONG POSITION IN H-SHARES OF WUXI APPTEC 2359.HK INCREASES TO 5.63% ON DEC 9 FROM 4.99% - HKEXUBS GROUP AG'S SHORT POSITION IN H-SHARES OF WUXI APPTEC 2359.HK INCREASES TO 4.15% ON DEC 9 FROM 3.51% - HKEXFurther company coverage: 2359.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","02359","LU1997245094.SGD","BK1576","LU0708995583.HKD","LU0052750758.USD","LU0456842615.SGD","LU1997245177.USD","LU2125910500.SGD","BK1583","LU0320764599.SGD","LU1046422090.SGD","LU2045819591.USD","BK1141","LU2488822045.USD","603259","BK0216"],"gpt_icon":0},{"id":"2491434185","title":"JPMorgan Chase & Co's Short Position in H-Shares of WuXi AppTec Increases to 3.23% on Dec 9 From 2.07% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2491434185","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491434185?lang=en_us&edition=fundamental","pubTime":"2024-12-13 17:17","pubTimestamp":1734081427,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0EE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2045819591.USD","603259","BK1576","LU0456842615.SGD","LU0708995583.HKD","02359","BK0216","LU0052750758.USD","LU2125910500.SGD","BK1141","LU2242644610.SGD","LU1046422090.SGD","BK1583","LU2488822045.USD","LU1997245094.SGD","LU1997245177.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2491349616","title":"UBS Group Ag's Long Position in H-Shares of WuXi AppTec Increases to 5.63% on Dec 9 From 4.99% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2491349616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491349616?lang=en_us&edition=fundamental","pubTime":"2024-12-13 17:10","pubTimestamp":1734081012,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2045819591.USD","603259","BK1576","LU0456842615.SGD","LU0708995583.HKD","02359","BK0216","LU0052750758.USD","LU2125910500.SGD","BK1141","LU2242644610.SGD","LU1046422090.SGD","BK1583","LU2488822045.USD","LU1997245094.SGD","LU1997245177.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2490830699","title":"BRIEF-Jpmorgan Chase & Co's Long Position In H Shares Of Wuxi Apptec Increases To 9.55% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2490830699","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490830699?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:22","pubTimestamp":1733916166,"startTime":"0","endTime":"0","summary":"BRIEF-Jpmorgan Chase & Co's Long Position In H Shares Of Wuxi Apptec Increases To 9.55% - HKEXDec 11 (Reuters) - HKEX:JPMORGAN CHASE & CO'S LONG POSITION IN H SHARES OF WUXI APPTEC INCREASES TO 9.55% ON DEC 6 FROM 8.98%Further company coverage: 2359.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","BK0216","LU0320764599.SGD","LU2045819591.USD","LU2242644610.SGD","BK1576","LU0456842615.SGD","BK1141","BK1583","LU2125910500.SGD","LU2488822045.USD","LU1046422090.SGD","LU1997245094.SGD","02359","603259","LU0708995583.HKD","LU0052750758.USD"],"gpt_icon":0},{"id":"2490836601","title":"JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Increases to 9.55% on Dec 6 From 8.98% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2490836601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490836601?lang=en_us&edition=fundamental","pubTime":"2024-12-11 17:35","pubTimestamp":1733909749,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","LU0456842615.SGD","BK1583","BK1141","LU1997245177.USD","LU2045819591.USD","LU0320764599.SGD","LU2242644610.SGD","02359","LU0708995583.HKD","LU1046422090.SGD","LU0052750758.USD","603259","LU2125910500.SGD","BK1576","BK0216","LU1997245094.SGD"],"gpt_icon":0},{"id":"2490435597","title":"Hong Kong Stocks Begin Week in Green; WuXi AppTec, WuXi Biologics Jump 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490435597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490435597?lang=en_us&edition=fundamental","pubTime":"2024-12-09 16:47","pubTimestamp":1733734028,"startTime":"0","endTime":"0","summary":"Hong Kong stocks rose for a second straight trading day on Monday, as hopes for further fiscal stimulus outweighed deflationary concerns and bolstered investor confidence.The Hang Seng Index soared 2.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOJW.SI","LU1242518931.SGD","LU1880383366.USD","LU0516422440.USD","LU1328277881.USD","LU0588546209.SGD","LU0140636845.USD","IE00B0JY6N72.USD","LU0164865239.USD","LU0417516738.SGD","LU0039217434.USD","513600","LU0572944931.SGD","BK1607","LU0359201612.USD","LU0149721374.USD","MCHmain","LU0326950275.SGD","LU0417516902.SGD","LU0345775950.USD","LU2045819591.USD","02833","LU0456827905.SGD","LU1481107354.HKD","LU0856984785.SGD","LU1719994722.HKD","LU1997245094.SGD","LU1242518857.USD","LU0819121731.USD","LU0051755006.USD","BK1502","LU1720050803.USD","LU2097828631.EUR","HHImain","HSI","BK1589","LU0823426308.USD","LU1688375341.USD","LU1813983027.USD","LU2125910500.SGD","603259","02359","BK1141","BK1193","81810","BK1610","BK1506","02269","LU0181495838.USD"],"gpt_icon":1}],"profile":{"ret":0,"listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","stockEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":-0.0925},{"period":"3month","weight":0.0225},{"period":"6month","weight":0.3559},{"period":"1year","weight":-0.2024},{"period":"ytd","weight":-0.0441}],"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"288799万元","compareEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.002},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.116},{"period":"ytd","weight":-0.0419}],"survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球生物医药行业提供一体化、端到端的新药研发和生产服务。公司主营业务可以分为化学业务、测试业务、生物学业务、细胞及基因疗法CTDMO业务、国内新药研发服务业务五大板块，服务范围覆盖从概念产生到商业化生产的整个流程，服务区域包括中国、美国、欧洲及其他区域。","serverTime":1736520146379,"listedPrice":21.6,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Apptec Co.,Ltd.(603259),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Wuxi Apptec Co.,Ltd.(603259) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Wuxi Apptec Co.,Ltd.,603259,Wuxi Apptec Co.,Ltd.股票,Wuxi Apptec Co.,Ltd.股票老虎,Wuxi Apptec Co.,Ltd.股票老虎国际,Wuxi Apptec Co.,Ltd.行情,Wuxi Apptec Co.,Ltd.股票行情,Wuxi Apptec Co.,Ltd.股价,Wuxi Apptec Co.,Ltd.股市,Wuxi Apptec Co.,Ltd.股票价格,Wuxi Apptec Co.,Ltd.股票交易,Wuxi Apptec Co.,Ltd.股票购买,Wuxi Apptec Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Apptec Co.,Ltd.(603259),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Wuxi Apptec Co.,Ltd.(603259) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}